| Effect of screening on colorectal cancer incidence and mortality associated with smoking, obesity and family history of colorectal cancer |
Adeyinka Laiyemo |
Howard University |
PLCO |
May 27, 2014 |
PLCO-88 |
| The role of morphologic computed tomography characteristics in the management of subsolid nodules |
Bram van Ginneken |
Radboud University Medical Center |
NLST |
May 23, 2014 |
NLST-74 |
| Evaluating long term outcomes and over diagnosis in lung cancer screening using the PLCO data |
Dongfeng Wu |
University of Louisville |
PLCO |
May 21, 2014 |
PLCO-86 |
| ovarian cancer screening in a high risk population |
Keith Terada |
University of Hawaii |
PLCO |
May 21, 2014 |
PLCO-89 |
| The implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis and cancer-specific mortality |
Nora Pashayan |
University College London |
PLCO |
May 20, 2014 |
PLCO-85 |
| Analysis of genetic variants in genome-wide level of colorectal cancer in multiple populations |
Yao Xue |
Nanjing Medical University |
PLCO |
May 20, 2014 |
PLCO-84 |
| Evaluating long term outcomes and over diagnosis in lung cancer screening using the NLST data |
Dongfeng Wu |
University of Louisville |
NLST |
May 16, 2014 |
NLST-73 |
| Redefining normal: personalized CA125 cutpoints for ovarian cancer screening |
Kathryn Terry |
Brigham and Women's Hospital / Harvard Medical School |
PLCO |
May 12, 2014 |
PLCO-82 |
| Factors affecting post lead time survival in NLST participants |
Grant Izmirlian |
National Cancer Institute |
NLST |
May 7, 2014 |
NLST-72 |
| NLST Results by Age |
Paul Pinsky |
NCI |
NLST |
May 5, 2014 |
NLST-71 |
| Individualized-risk based computed tomography lung cancer screening strategies: an evaluation using comparative microsimulation modeling |
Kevin ten Haaf |
Erasmus MC |
PLCO |
May 2, 2014 |
PLCO-83 |
| Individualized-risk based computed tomography lung cancer screening strategies: an evaluation using comparative microsimulation modeling |
Kevin ten Haaf |
Erasmus MC |
NLST |
May 2, 2014 |
NLST-70 |
| Inflammation-related factors and endometrial cancer risk: an E2C2 Study |
Christina Nagle |
QIMR |
PLCO |
Apr 29, 2014 |
PLCO-81 |
| Ovarian Volume and Hormone Levels |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Apr 29, 2014 |
PLCO-71 |
| Translating Gene-Calcium Interactions to Precision Medicine for Colorectal Cancer |
Qi Dai |
Vanderbilt University |
PLCO |
Apr 29, 2014 |
PLCO-80 |
| Calculating risk of oropharyngeal cancer by HPV16 E6 serostatus |
Aimee Kreimer |
NCI, DCEG, IIB |
PLCO |
Apr 18, 2014 |
PLCO-75 |
| Evaluating cancer mortality in the National Lung Screening Trial |
Chiung-Yu Huang |
Johns Hopkins University |
NLST |
Apr 18, 2014 |
NLST-69 |
| Practice patterns for FDG PET-CT and FDG PET Imaging During Lung Cancer Screening Evaluation |
Viswam Nair |
Leland Stanford Junior University |
NLST |
Apr 14, 2014 |
NLST-68 |
| Demographic, diet, and lifestyle factors associated with risk of thyroid cancer and outcome disparities. |
Michael Singer |
Henry Ford Health System |
PLCO |
Apr 11, 2014 |
PLCO-79 |
| The Influence of the Dietary Inflammatory Index (DII) on Cancer Risk |
James Hebert |
Arnold School of Public Health University of South Carolina |
PLCO |
Apr 11, 2014 |
PLCO-76 |
